The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Erythropoietin Drug Market Research Report 2024

Global Erythropoietin Drug Market Research Report 2024

Publishing Date : Jan, 2024

License Type :
 

Report Code : 1432105

No of Pages : 71

Synopsis
Erythropoietin drugs are also known as hematopoietin. It is a glycoprotein hormone that controls erythropoiesis or production of RBC. They are used in treatment of different diseases like cancer, chronic renal diseases,
The global Erythropoietin Drug market was valued at US$ 371 million in 2023 and is anticipated to reach US$ 471.2 million by 2030, witnessing a CAGR of 3.4% during the forecast period 2024-2030.
Global erythropoietin drug market is segmented on the basis of type of product into biosimilars, first generation formulation and second generation formulation. On the basis of application market is segmented as oncology, renal diseases, HIV and other and on the basis of end user they are segmented into hospital and pharmacy.
This report aims to provide a comprehensive presentation of the global market for Erythropoietin Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Erythropoietin Drug.
Report Scope
The Erythropoietin Drug market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Erythropoietin Drug market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Erythropoietin Drug companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Amgen
Johnson & Johnson
Roche
Galenica
Emcure
Kyowa Hakko Kirin
3SBio
Biocon
LG Life Sciences
Segment by Type
Epoetin-alfa
Darbepoetin-alfa
Epoetin-beta
Others
Segment by Application
Anemia
Kidney Disorders
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Erythropoietin Drug companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Erythropoietin Drug Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Epoetin-alfa
1.2.3 Darbepoetin-alfa
1.2.4 Epoetin-beta
1.2.5 Others
1.3 Market by Application
1.3.1 Global Erythropoietin Drug Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Anemia
1.3.3 Kidney Disorders
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Erythropoietin Drug Market Perspective (2019-2030)
2.2 Erythropoietin Drug Growth Trends by Region
2.2.1 Global Erythropoietin Drug Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Erythropoietin Drug Historic Market Size by Region (2019-2024)
2.2.3 Erythropoietin Drug Forecasted Market Size by Region (2025-2030)
2.3 Erythropoietin Drug Market Dynamics
2.3.1 Erythropoietin Drug Industry Trends
2.3.2 Erythropoietin Drug Market Drivers
2.3.3 Erythropoietin Drug Market Challenges
2.3.4 Erythropoietin Drug Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Erythropoietin Drug Players by Revenue
3.1.1 Global Top Erythropoietin Drug Players by Revenue (2019-2024)
3.1.2 Global Erythropoietin Drug Revenue Market Share by Players (2019-2024)
3.2 Global Erythropoietin Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Erythropoietin Drug Revenue
3.4 Global Erythropoietin Drug Market Concentration Ratio
3.4.1 Global Erythropoietin Drug Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Erythropoietin Drug Revenue in 2023
3.5 Erythropoietin Drug Key Players Head office and Area Served
3.6 Key Players Erythropoietin Drug Product Solution and Service
3.7 Date of Enter into Erythropoietin Drug Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Erythropoietin Drug Breakdown Data by Type
4.1 Global Erythropoietin Drug Historic Market Size by Type (2019-2024)
4.2 Global Erythropoietin Drug Forecasted Market Size by Type (2025-2030)
5 Erythropoietin Drug Breakdown Data by Application
5.1 Global Erythropoietin Drug Historic Market Size by Application (2019-2024)
5.2 Global Erythropoietin Drug Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Erythropoietin Drug Market Size (2019-2030)
6.2 North America Erythropoietin Drug Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Erythropoietin Drug Market Size by Country (2019-2024)
6.4 North America Erythropoietin Drug Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Erythropoietin Drug Market Size (2019-2030)
7.2 Europe Erythropoietin Drug Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Erythropoietin Drug Market Size by Country (2019-2024)
7.4 Europe Erythropoietin Drug Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Erythropoietin Drug Market Size (2019-2030)
8.2 Asia-Pacific Erythropoietin Drug Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Erythropoietin Drug Market Size by Region (2019-2024)
8.4 Asia-Pacific Erythropoietin Drug Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Erythropoietin Drug Market Size (2019-2030)
9.2 Latin America Erythropoietin Drug Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Erythropoietin Drug Market Size by Country (2019-2024)
9.4 Latin America Erythropoietin Drug Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Erythropoietin Drug Market Size (2019-2030)
10.2 Middle East & Africa Erythropoietin Drug Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Erythropoietin Drug Market Size by Country (2019-2024)
10.4 Middle East & Africa Erythropoietin Drug Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Amgen
11.1.1 Amgen Company Detail
11.1.2 Amgen Business Overview
11.1.3 Amgen Erythropoietin Drug Introduction
11.1.4 Amgen Revenue in Erythropoietin Drug Business (2019-2024)
11.1.5 Amgen Recent Development
11.2 Johnson & Johnson
11.2.1 Johnson & Johnson Company Detail
11.2.2 Johnson & Johnson Business Overview
11.2.3 Johnson & Johnson Erythropoietin Drug Introduction
11.2.4 Johnson & Johnson Revenue in Erythropoietin Drug Business (2019-2024)
11.2.5 Johnson & Johnson Recent Development
11.3 Roche
11.3.1 Roche Company Detail
11.3.2 Roche Business Overview
11.3.3 Roche Erythropoietin Drug Introduction
11.3.4 Roche Revenue in Erythropoietin Drug Business (2019-2024)
11.3.5 Roche Recent Development
11.4 Galenica
11.4.1 Galenica Company Detail
11.4.2 Galenica Business Overview
11.4.3 Galenica Erythropoietin Drug Introduction
11.4.4 Galenica Revenue in Erythropoietin Drug Business (2019-2024)
11.4.5 Galenica Recent Development
11.5 Emcure
11.5.1 Emcure Company Detail
11.5.2 Emcure Business Overview
11.5.3 Emcure Erythropoietin Drug Introduction
11.5.4 Emcure Revenue in Erythropoietin Drug Business (2019-2024)
11.5.5 Emcure Recent Development
11.6 Kyowa Hakko Kirin
11.6.1 Kyowa Hakko Kirin Company Detail
11.6.2 Kyowa Hakko Kirin Business Overview
11.6.3 Kyowa Hakko Kirin Erythropoietin Drug Introduction
11.6.4 Kyowa Hakko Kirin Revenue in Erythropoietin Drug Business (2019-2024)
11.6.5 Kyowa Hakko Kirin Recent Development
11.7 3SBio
11.7.1 3SBio Company Detail
11.7.2 3SBio Business Overview
11.7.3 3SBio Erythropoietin Drug Introduction
11.7.4 3SBio Revenue in Erythropoietin Drug Business (2019-2024)
11.7.5 3SBio Recent Development
11.8 Biocon
11.8.1 Biocon Company Detail
11.8.2 Biocon Business Overview
11.8.3 Biocon Erythropoietin Drug Introduction
11.8.4 Biocon Revenue in Erythropoietin Drug Business (2019-2024)
11.8.5 Biocon Recent Development
11.9 LG Life Sciences
11.9.1 LG Life Sciences Company Detail
11.9.2 LG Life Sciences Business Overview
11.9.3 LG Life Sciences Erythropoietin Drug Introduction
11.9.4 LG Life Sciences Revenue in Erythropoietin Drug Business (2019-2024)
11.9.5 LG Life Sciences Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

Published By : QY Research

Why ‘The Market Reports’